STING agonist-47
STING agonist-47 is a STING agonist with an EC50 of 0.72 μM and a Kd of 176 nM. STING agonist-47 is a dimer of MSA-2 (HY-136927). STING agonist-47 can be used for the research of cancer, such as breast cancer.
For research use only. We do not sell to patients.
- Formula: C28H26O8S4
- Molecular Weight:618.76
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
In Vitro
STING agonist-47 (Compound SC2S) (0.71 μM, 24 h) activates the interferon pathway in THP-1 Lucia ISG cells[1].
STING agonist-47 (5 μM, 0.5-4 h) treatment of THP-1 Lucia ISG cells leads to significantly increased phosphorylation levels of key STING pathway proteins (pSTING, pTBK1, pIRF3)[1].
STING agonist-47 (25 μM, 6 h) induces IFN-β secretion in THP-1 cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
In Vivo
STING agonist-47 (8.6 mg/kg, intratumoral injection) inhibits tumor growth in BALB/c mice inoculated with CT26mβGUS colon cancer cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:2-day-post-fertilization (dpf) casper or nacre mutant zebrafish xenografted with Hs578T triple-negative breast cancer cells[1]
-
Dosage:0.62 μM
-
Administration:Immersion administration, daily from 1 day post-infection to 4 for 3 consecutive days
-
Result:Induced tumor cell apoptosis (activates Caspase3).
Reduced tumor size and increased the number of tumor-associated macrophages (TAM).
Promoted macrophage polarization to the proinflammatory M1 phenotype (expressing TNF).
Chemical Information
-
Molecular Weight 618.76
-
Formula C28H26O8S4
-
SMILES
COC1=CC2=C(C=C1SCCSC3=CC4=C(SC(C(CCC(O)=O)=O)=C4)C=C3OC)C=C(S2)C(CCC(O)=O)=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Research Protocol for Multiple sequence alignment
Multiple sequence alignment is a computational method for arranging DNA, RNA, or protein sequences so that homologous residues or nucleotides are placed in the same columns, enabling conservation analysis, motif detection, structure prediction, phylogenetic inference, and evolutionary interpretation. MSA accuracy depends on sequence similarity, length variation, insertions and deletions, domain architecture, sequence number, and algorithm choice; therefore, no single aligner is optimal for every dataset. Commonly used MSA tools include MAFFT, MUSCLE, Clustal Omega, and T-Coffee; MAFFT provides multiple strategies for diverse alignment problems, MUSCLE emphasizes speed and accuracy, Clustal Omega scales well to large protein datasets, and T-Coffee uses consistency information to improve alignment reliability. Unresolved issues include alignment uncertainty in divergent sequences, over-alignment of unrelated regions, variable effects of automated trimming, and propagation of alignment er
-
Breast Cancer Modeling
Breast cancer is a heterogeneous cancer, and it has been distinguished into four subtypes: luminal A, luminal B, HER2-positive and basal-like. Molecular mutations, epigenetic alterations, hormone exposure and immune microenvironment are related to the progression of breast cancer.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)